Enhanced Capabilities Enable Phillips-Medisize to Better Serve Customers
HUDSON, WI – September 26, 2018 – Phillips-Medisize, a Molex company, an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics and medical device industries announces enhanced capabilities which provide for compelling and unique ways of partnering with customers. Please visit our new website www.phillipsmedisize.com.
Through innovation leadership, true end-to-end services, electronics integration, and technology accelerators, our unique capabilities create more value for our customers. Our people, processes, integrated quality systems, and global footprint result in collaborative innovation, accelerated time to market, reduced risk and maximized development resources.
“At Phillips-Medisize, we believe innovation grows at the intersection of market needs and emerging technologies,” said Matt Jennings, CEO and President, Phillips-Medisize. “By driving innovation at every level and project phase, we help customers bring better drug delivery devices and connected health solutions to market swiftly, with increased confidence.”
Our approach to electronics integration and connected health is based on experience. With expertise in electronics hardware, software engineering, PCBA manufacturing and assembly, we have capabilities to partner with customers to create connected health solutions. Connected health platforms are an efficient way to collect patient data and provide instructional content for patients, healthcare providers, caregivers, and payers.
“Phillips-Medisize pushes the boundaries of technology-driven innovation to give their customers a competitive edge in the design, development, and commercial manufacturing of differentiated drug delivery devices and connected health solutions,” adds Joe Nelligan, President and Chief Operating Officer, Molex.
Each year Phillips-Medisize supports the innovation, development and manufacture of hundreds of millions of commercially successful solutions to the pharmaceutical, diagnostic and medical device industries.
Please visit our new website: www.phillipsmedisize.com.
Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of innovation, development, manufacturing, and post-launch services to the pharmaceutical, diagnostics, medical device and specialty commercial markets. Post-launch services include Connected Health applications and data services. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize’s core advantage is the knowledge of its people to integrate design, molding and automation, providing innovative, high-quality manufacturing solutions. For more information, please visit www.phillipsmedisize.com or www.molex.com.
For more information, contact:
Phone +1 630 408 9164
Phone +1 715 377 7261
Paula Kasper (Europe)